Company
Headquarters: Sao Paulo, SP, Brazil
CEO: Ms. Karla Maciel Dolabella
R$1.50 Billion
BRL as of July 1, 2024
US$264.2 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $204.45 B |
| Danaher | $177.21 B |
| Siemens Healthineers AG | $63.84 B |
| DexCom, Inc. | $45.21 B |
| Lonza Group Ltd | $39.85 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Centro de Imagem Diagnósticos S.A. provides diagnostic medicine services in Brazil. Its diagnostic imaging services include imaging diagnosis and chart-based diagnosis; nuclear medicine and cytology; pathological anatomy; and clinical tests. The company also engages in the provision of health consulting, advisory, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other media for the dissemination of scientific knowledge; and grant and management of business franchises. Centro de Imagem Diagnósticos S.A. was founded in 1992 and is headquartered in São Paulo, Brazil.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Centro de Imagem Diagnosticos SA has the following listings and related stock indices.
Stock: Bovespa: AALR3 wb_incandescent